Iodine-131 RPS-001 is a PSMA-targeting radioligand showing promise in prostate cancer therapy trials.
Radiotherapeutics

Iodine-131 RPS-001: A Promising Radiolabelled Molecule in Prostate Cancer Therapy

Summary: Iodine-131 RPS-001 (also known as 131I-MIP-1095) is a novel radiolabelled small molecule targeting the prostate-specific membrane antigen (PSMA) receptor, […]

Iodine-131 RPS-001: A Promising Radiolabelled Molecule in Prostate Cancer Therapy Read Post »